清肺口服液治疗小儿病毒性肺炎58例疗效观察  

The observation of effects of Qingfei oral liquid therapy on 58 cases of children with children’s virus pneumonia

作　　者：任献国[1] 刘光陵[1] 夏正坤[1] 高远赋[1] 伏洁[1] 张连丰[1] 付元凤[1] 樊忠民[1] 高春林[1] 章新宇[1] 

机构地区：[1]南京军区南京总医院儿科,江苏南京210002

出　　处：《医学研究生学报》2004年第7期601-603,共3页Journal of Medical Postgraduates

基　　金：国家"十五"科技攻关基金资助项目 (批准号 :2 0 0 1BA70 1A16B)

摘　　要：目的 :评价清肺口服液 (南京中医药大学附属医院院内制剂 )治疗小儿病毒性肺炎痰热闭肺证的有效性。方法 :选择 87例符合小儿病毒性肺炎痰热闭肺证诊断标准的患儿 ,按随机化原则分为试验组 (5 8例 )和对照组 (2 9例 ) ,分别给予清肺口服液、利巴韦林注射液治疗 ,观察疗程为 1 0天。　结果 :试验组患儿痊愈 5 0例 (86 .2 1 % ) ,显效 5例 (8.6 2 % ) ;对照组患儿痊愈 1 5例 (5 1 .72 % ) ,显效 1 4例 (4 8.2 8% ) ,经秩和检验P <0 .0 0 0 1 ,试验组疗效显著优于对照组。咳嗽、肺部湿啰音、Ｘ线全胸片等指标好转情况 ,试验组优于对照组。发热、气促等指标好转情况 ,两组疗效无显著性差异。　结论Objective:To assess the efficacy of Qingfei oral liquid(produced by the affiliated hospital of Nanjing University of TCM) in treating accumulation of phlegm heat syndrome of children′s virus pneumonia. Methods:87 cases that met the criterion of accumulation of phlegm heat syndrome of children’s virus pneumonia were selected. All subjects were divided randomly into two groups, test group(58 cases) and controlled group(29 cases). Test group was given Qingfei oral liquid. Controlled group was infused ribavirin injection and oral placebo. The observing course was 10 days. Results:The cured cases of test group were 50(86.21%), the significant effective cases of test group were 5(8.62%). The cured cases of controlled group were 15(51.72%), the significant effective cases of controlled group were 14 (48.28%) . With rank sum test ,it showed that P < 0.000 1. The effect of test group was much better than of the controlled group. Compared with the controlled group, the indexes of test group of cough, auscultation on lung, X ray of chest were much better. Conclusion:Qingfei oral liquid is effective in treating accumulation of phlegm heat syndrome of children's virus pneumonia.

关 键 词：清肺口服液 小儿病毒性肺炎 痰热闭肺证 

分 类 号：R563.1[医药卫生—呼吸系统]